Skip to main content

Advertisement

Log in

Optimal follow-up intervals in active surveillance of renal masses in patients with von Hippel-Lindau disease

  • Oncology
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To estimate an optimal follow-up (FU) interval for von Hippel-Lindau (VHL) patients with renal masses (RMs) by determining tumour growth rates from growth curves.

Methods

Thirty lesions (47.6 %) were classified as solid tumours (STs) and 33 (52.4 %) as complex cysts (CCs). Variations in lesion volume over time were analyzed. For 53 lesions, we calculated the growth rate during the period when the volume of the lesion changed most rapidly, and called this the fast growth rate (FGR).

Results

The STs initially grew fast, followed by a period of slower growth. The CCs varied in volume over time, associated with variable amounts of their fluid component. The FGR correlated better with the latest volume for STs (r = 0.905) than for CCs (r = 0.780). An optimal FU interval between 3 and 12 months was derived by combining the FGR calculated from the curve with the latest volume measured.

Conclusions

Analyzing growth curves and related kinetic parameters for RMs in VHL patients could be useful with a view to optimizing the subsequent FU interval and improving the active surveillance program.

Key Points

Measuring volume changes over time enables tumour growth curves to be charted.

Renal solid tumours increase in volume with a typical sigmoidal curve.

Complex cysts may increase and decrease in volume spontaneously over time.

The fast growth rate of solid tumours correlates with their latest volume.

The fast growth rate can orient the scheduling of subsequent follow-ups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

CCs:

Complex cysts

DT:

Doubling time

FGR:

Fast growth rate

FU:

Follow-up

GR:

Growth rate

MRI:

Magnetic resonance imaging

RCC:

Renal cell carcinoma

RMs:

Renal masses

STs:

Solid tumours

VHL:

Von Hippel-Lindau

References

  1. Lonser RR, Glenn GM, Walther M et al (2003) Von hippel-lindau disease. Lancet 361:2059–2067

    Article  CAS  PubMed  Google Scholar 

  2. Verine J, Pluvinage A, Bousquet G et al (2010) Hereditary renal cancer syndromes: An update of a systematic review. Eur Urol 58:701–710

    Article  PubMed  Google Scholar 

  3. Kim JJ, Rini BI, Hansel DE (2010) Von hippel lindau syndrome. Adv Exp Med Biol 685:228–249

    CAS  PubMed  Google Scholar 

  4. Latif F, Tory K, Gnarra J et al (1993) Identification of the von hippel-lindau disease tumor suppressor gene. Science 260:1317–1320

    Article  CAS  PubMed  Google Scholar 

  5. Meister M, Choyke P, Anderson C, Patel U (2009) Radiological evaluation, management, and surveillance of renal masses in von hippel-lindau disease. Clin Radiol 64:589–600

    Article  CAS  PubMed  Google Scholar 

  6. Choyke PL, Glenn GM, Walther MM et al (1992) The natural history of renal lesions in von hippel-lindau disease: A serial CT study in 28 patients. AJR Am J Roentgenol 159:1229–1234

    Article  CAS  PubMed  Google Scholar 

  7. Walther MM, Choyke PL, Glenn G et al (1999) Renal cancer in families with hereditary renal cancer: Prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 161:1475–1479

    Article  CAS  PubMed  Google Scholar 

  8. Duffey BG, Choyke PL, Glenn G et al (2004) The relationship between renal tumor size and metastases in patients with von hippel-lindau disease. J Urol 172:63–65

    Article  PubMed  Google Scholar 

  9. Ploussard G, Droupy S, Ferlicot S et al (2007) Local recurrence after nephron-sparing surgery in von hippel-lindau disease. Urology 70:435–439

    Article  PubMed  Google Scholar 

  10. Boss A, Clasen S, Kuczyk M, Schick F, Pereira PL (2007) Image-guided radiofrequency ablation of renal cell carcinoma. Eur Radiol 17:725–733

    Article  PubMed  Google Scholar 

  11. Shingleton WB, Sewell PE Jr (2002) Percutaneous renal cryoablation of renal tumors in patients with von hippel-lindau disease. J Urol 167:1268–1270

    Article  PubMed  Google Scholar 

  12. Afenya EK, Calderon CP (2000) Diverse ideas on the growth kinetics of disseminated cancer cells. Bull Math Biol 62:527–542

    Article  CAS  PubMed  Google Scholar 

  13. Bajzer Z (1999) Gompertzian growth as a self-similar and allometric process. Growth Dev Aging 63:3–11

    CAS  PubMed  Google Scholar 

  14. Domingues JS (2012) Gompertz model: Resolution and analysis for tumors. J Math Model Appl 1:70–77

    Google Scholar 

  15. Collins VP, Loeffler RK, Tivey H (1956) Observations on growth rates of human tumors. Am J Roentgenol Radium Ther Nucl Med 76:988

    CAS  PubMed  Google Scholar 

  16. Jilg CA, Neumann HP, Glasker S et al (2012) Growth kinetics in von hippel-lindau-associated renal cell carcinoma. Urol Int 88:71–78

    Article  CAS  PubMed  Google Scholar 

  17. Zhang J, Pan JH, Dong BJ, Xue W, Liu DM, Huang YR (2012) Active surveillance of renal masses in von hippel-lindau disease: Growth rates and clinical outcome over a median follow-up period of 56 months. Fam Cancer 11:209–214

    Article  CAS  PubMed  Google Scholar 

  18. Bosniak MA (1997) The use of the bosniak classification system for renal cysts and cystic tumors. J Urol 157:1852–1853

    Article  CAS  PubMed  Google Scholar 

  19. Nikken JJ, Krestin GP (2007) MRI of the kidney-state of the art. Eur Radiol 17:2780–2793

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Pedrosa I, Chou MT, Ngo L et al (2008) MR classification of renal masses with pathologic correlation. Eur Radiol 18:365–375

    Article  PubMed  Google Scholar 

  21. Crispen PL, Wong YN, Greenberg RE, Chen DY, Uzzo RG (2008) Predicting growth of solid renal masses under active surveillance. Urol Oncol 26:555–559

    Article  PubMed Central  PubMed  Google Scholar 

  22. Choi SJ, Kim HS, Ahn SJ, Park Y, Choi HY (2012) Differentiating radiological features of rapid- and slow-growing renal cell carcinoma using multidetector computed tomography. J Comput Assist Tomogr 36:313–318

    Article  PubMed  Google Scholar 

  23. Kurup AN, Thompson RH, Leibovich BC et al (2012) Renal oncocytoma growth rates before intervention. BJU Int 110:1444–1448

    Article  PubMed  Google Scholar 

  24. Li XS, Yao L, Gong K et al (2012) Growth pattern of renal cell carcinoma (RCC) in patients with delayed surgical intervention. J Cancer Res Clin Oncol 138:269–274

    Article  PubMed  Google Scholar 

  25. Kassouf W, Aprikian AG, Laplante M, Tanguay S (2004) Natural history of renal masses followed expectantly. J Urol 171:111–113

    Article  CAS  PubMed  Google Scholar 

  26. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA (2004) The natural history of incidentally detected small renal masses. Cancer 100:738–745

    Article  PubMed  Google Scholar 

  27. Lamb GW, Bromwich EJ, Vasey P, Aitchison M (2004) Management of renal masses in patients medically unsuitable for nephrectomy–natural history, complications, and outcome. Urology 64:909–913

    Article  PubMed  Google Scholar 

  28. Lee JY, Kim CK, Choi D, Park BK (2008) Volume doubling time and growth rate of renal cell carcinoma determined by helical CT: A single-institution experience. Eur Radiol 18:731–737

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Andrea Azzalini for help in preparing the illustrations. The scientific guarantor of this publication is Gisella Gennaro. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. One of the authors has significant statistical expertise. Institutional Review Board approval was obtained. Written informed consent was not required for this study because it retrospectively evaluated images already acquired for the standard patient FU, with no effect on the patients themselves. The study subjects have never been previously reported. Methodology: retrospective, observational, performed at one institution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gisella Gennaro.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pomerri, F., Opocher, G., Bosco, C.D. et al. Optimal follow-up intervals in active surveillance of renal masses in patients with von Hippel-Lindau disease. Eur Radiol 25, 2025–2032 (2015). https://doi.org/10.1007/s00330-015-3591-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-015-3591-9

Keywords

Navigation